A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Stdy to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain Following Laparoscopic or Robotic-assisted Laparoscopic Gastrectomy
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs VVZ 149 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Vivozon
- 31 Oct 2017 Status changed from recruiting to completed.
- 28 Sep 2016 Planned End Date changed from 1 May 2018 to 1 Aug 2017.
- 28 Sep 2016 Planned primary completion date changed from 1 May 2018 to 1 Aug 2017.